Creative Financial Designs’s AnaptysBio ANAB Stock Holding History

Creative Financial Designs’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-16	Closed	-$297	–	2016
2025 Q1	$297	Buy	+16	New	+$267	﹤0.01%	1955

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Creative Financial Designs's ANAB Position: Q2 2025 in Review

Creative Financial Designs sold out of AnaptysBio (ANAB) in Q2 2025, closing a stake of 16 shares — an estimated $297 sold.

Creative Financial Designs first reported a position in ANAB in Q1 2025 and held it in 1 quarter. The position peaked at $297 in Q1 2025. 147 funds tracked by Wall St. Rank hold ANAB as of Q2 2025.

Creative Financial Designs reported no remaining AnaptysBio position as of Q2 2025 after selling out during the quarter.
Creative Financial Designs sold 16 AnaptysBio shares in Q2 2025, an estimated $297.
Creative Financial Designs first reported a position in AnaptysBio in Q1 2025 and held it in 1 quarter.
Creative Financial Designs's AnaptysBio position peaked at $297 in Q1 2025.
147 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2025.

Based on Creative Financial Designs's 13F filing for Q2 2025, filed 4 Aug 2025.